📰 GeneralCNBCFriday, September 25, 2026 at 9:58 AM UTC56m ago

Pharma stock soars 150% on injectables deal with Wegovy maker Novo

Shares in Swedish microcap stock Nanexa more than doubled after the drug-delivery group revealed a licensing deal with European pharma giant Novo Nordisk

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation News.

← Back to News

Pharma stock soars 150% on injectables deal with Wegovy maker Novo

📰 Related Stories

See which incumbents have the biggest cash advantage in the tightest U.S. House races

Chatbots Are Not Your Friends

Mark Zuckerberg Is Trying Something On

U.S. Treasury yields tick higher as global bond rout slows

An absence of significant economic slowdown doesn't mean no signs of stagflation risks. Here's why

Lightspeed targets $250M for new India fund, focusing on early-stage AI